バイオリアクター市場：メカニズム、用途、制御タイプ、材料、規模、使用性、エンドユーザー別-2025～2030年世界予測

バイオリアクター市場は、2023年に32億6,000万米ドルと評価され、2024年には35億7,000万米ドルに達すると予測され、CAGR 9.46%で成長し、2030年には61億5,000万米ドルに達すると予測されています。

バイオリアクターは、医薬品、バイオ燃料、その他の製品を生産するための微生物、細胞、組織の培養において重要な役割を果たす、バイオ製造業に不可欠なコンポーネントです。バイオリアクターの必要性は、バイオテクノロジーと工業プロセスの進歩を推進する生物製剤とサステイナブルエネルギーソリューションに対する需要の高まりから生じています。その用途は医薬品製造、廃水処理、飲食品産業、農業に及び、エンドユーザーは主に製薬会社、研究所、環境機関です。バイオリアクターの市場は、自動制御やモニタリングシステムの改善といった技術進歩の影響を大きく受けており、効率と歩留まりを向上させています。個別化医療や再生療法が新たな成長機会をもたらすなど、市場機会は豊富です。こうした機会を活用するため、企業は拡大性と生産収率の向上に焦点を当てた共同研究への投資を行うべきです。しかし、市場は高い初期投資コスト、複雑な規制の枠組み、汚染や拡大性に関する技術的問題といった課題に直面しています。これらの限界に対処するには、設計とプロセスの最適化におけるイノベーションが必要です。さらに、シングルユースバイオリアクターは、費用対効果が高く、汚染リスクが低いことから、技術革新のための有望なセグメントとして注目されています。モジュール性と適応性に焦点を当てたバイオリアクター設計の調査は、事業の成長をさらに後押しする可能性があります。バイオリアクター市場の性質は非常にダイナミックであり、急速な技術進歩や、バイオ医薬品やサステイナブル製品に対する消費者の需要の進化に後押しされています。戦略的パートナーシップや合併は、重要なリソースや技術的専門知識へのアクセスを確保し、競合をもたらす可能性があります。まとめると、バイオリアクター市場の将来は、継続的な技術革新、的確な規制対応、そして新たな動向と消費者ニーズに効果的に対応するための戦略的ポジショニングにあります。

市場力学：急速に進化するバイオリアクター市場の主要市場洞察を公開

バイオリアクター市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネス機会の獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • バイオ医薬品と生物製剤産業の急成長
  • シングルユースバイオリアクター（サブ）とハイブリッドバイオリアクターの採用
• 市場抑制要因
  • バイオリアクターのメンテナンスの問題と消費電力の高さ
• 市場機会
  • 新規バイオリアクター開発における絶え間ない技術進歩
  • 廃水処理プロセスにおけるバイオリアクターの高い可能性
• 市場課題
  • バイオリアクターの使用に伴う安全性と環境への懸念

ポーターのファイブフォース：バイオリアクター市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、バイオリアクター市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：バイオリアクター市場における外部からの影響の把握

外部マクロ環境要因は、バイオリアクター市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：バイオリアクター市場における競合情勢の把握

バイオリアクター市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：バイオリアクター市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、バイオリアクター市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限はベンダーを明確かつ正確に区分し、ユーザーが戦略目標に最適なパートナーやソリューションを特定するのに役立ちます。

本レポートは、主要な注目セグメントを網羅した包括的な市場分析を提供しています。

1.市場の浸透度：産業主要企業の広範なデータを含む、現在の市場環境の詳細なレビュー。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • バイオ医薬品と生物製剤産業の急速な成長
    • シングルユースバイオリアクター（サブ）とハイブリッドバイオリアクターの採用
  • 抑制要因
    • バイオリアクターのメンテナンスの問題と高電力消費の問題
  • 機会
    • 新しいバイオリアクターの開発における継続的な技術進歩
    • 廃水処理プロセスにおけるバイオリアクターの高い可能性
  • 課題
    • バイオリアクターの使用に関連する安全性と環境に関する懸念
• 市場セグメンテーション分析
  • メカニズム：光合成微生物の増殖のための光バイオリアクターの採用
  • 用途：大量処理能力により、さまざまな産業の本格的な生産に適している
  • 制御タイプ：プロセス制御の精度と一貫性が高いため、自動化されたバイオリアクターを採用
  • 材料：耐久性と拡大性により、製薬産業とバイオテクノロジー産業でステンレス鋼の使用が増加
  • 規模：パイロットスケールと小規模商業製造プロセスにおける200L～1500Lのバイオリアクターの適合性
  • 使用性：柔軟性と交差汚染のリスクの低減のため、使い捨てのバイオリアクターが好まれる
  • エンドユーザー：モノクローナル抗体やワクチンなどのバイオ医薬品の製造におけるバイオ医薬品産業での適用範囲が拡大
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 バイオリアクター市場：メカニズム別

• イントロダクション
• 気泡ポンプバイオリアクター
• ベンチトップバイオリアクター
• バブルコラムバイオリアクター
• 連続撹拌タンクバイオリアクター
• 流動床バイオリアクター
• 微生物バイオリアクター
• マルチパラレルバイオリアクター
• パックベッドバイオリアクター
• 光バイオリアクター

第7章 バイオリアクター市場：用途別

• イントロダクション
• 本格生産
• ラボスケールの生産
• パイロット規模の生産

第8章 バイオリアクター市場：制御タイプ別

• イントロダクション
• 自動
• 手動

第9章 バイオリアクター市場：材料別

• イントロダクション
• ガラス
• ステンレス鋼

第10章 バイオリアクター市場：規模別

• イントロダクション
• 1,500～4,000L
• 200～1500L
• 20～200L
• 5～20L
• 4,000L以上

第11章 バイオリアクター市場：使用性別

• イントロダクション
• 再利用可能
• 使い捨て

第12章 バイオリアクター市場：エンドユーザー別

• イントロダクション
• バイオ医薬品企業と製造業者
• 契約製造組織と契約研究組織
• 埋立地と廃棄物治療施設
• 研究開発部門と研究所

第13章 南北アメリカのバイオリアクター市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第14章 アジア太平洋のバイオリアクター市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第15章 欧州・中東・アフリカのバイオリアクター市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第16章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
  • デンマークでの拡大により、AGC Biologicsのバイオリアクターの容量が倍増し、バイオ医薬品の需要増加に対応
  • WuXiはバイオリアクターの統合による戦略的なバイオプロセス拡大の好例であり、増大する生物製剤の需要に対応
  • Caladan Bioは革新的なベンチトップ型医療機器の開発に500万米ドルのシードラウンドで革命を起こす
  • SartoriusバイオリアクターがEmersonの技術を統合し、新しい治療法の市場投入を加速
  • CytivaとPallのライフサイエンス事業の合併が完了
  • PBS BIoTechとdenovoMATRIXが協力し、細胞・遺伝子治療の製造プロセスを強化
  • LonzaとAdva Biotechnology Ltd.は、ロンザの特許ライセンスにより自動化されたバイオリアクターの利用と利用を拡大することに合意
  • Novo Holdings、LePure BIoTechのシリーズC資金調達を共同主導
  • PBS Biotech、細胞治療クライアント向け使い捨て製造製品とサービスを拡大するため2,200万米ドルを調達
  • Merck、Erbi Biosystemsの買収により灌流マイクロバイオリアクターのリーダーを獲得
  • Solaris BIoTechとWildtype、養殖魚介類の大規模生産に関する契約を発表
  • STEMCELL TechnologiesとPBS BIoTechが提携し、ヒト多能性幹細胞3D培養の堅牢なスケールアップを実現
  • Stamm BIoTech、デスクトップ3Dプリンティングバイオリアクターの開発に1,700万米ドルを調達

企業一覧

• 3D BIoTek LLC
• ABEC, Inc.
• Adolf Kuhner AG
• BBI-bIoTech GmbH
• Belach BIoTeknik AB legal
• Bioengineering AG
• Bionet Servicios Tecnicos, SL
• Broadley-James Corporation
• Cell Culture Company, LLC
• Cellexus Limited
• CerCell A/S
• Cesco Bioengineering Co., Ltd. acquired by Esco Lifescience Group
• Danaher Corporation
• Distek, Inc.
• Electrolab BIoTech Limited
• Eppendorf SE
• FiberCell Systems Inc.
• G&G Technologies, Inc.
• GEA Group AG
• Getinge AB
• IKA-Werke GmbH & CO. KG
• Infors AG
• Lonza Group AG
• Merck KGaA
• PBS BIoTech, Inc.
• Pierre Guerin SAS
• Praj Industries Limited
• Sartorius AG
• Shanghai LePure BIoTech Co., Ltd.
• Solaris BIoTechnolgy Srl by Donaldson Company, Inc.
• Solida BIoTech GmBH
• Terumo Corporation
• Thermo Fisher Scientific Inc.
• WuXi Biologics（Cayman）Inc.
• ZETA GmbH

LIST OF FIGURES

• FIGURE 1. BIOREACTORS MARKET RESEARCH PROCESS
• FIGURE 2. BIOREACTORS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BIOREACTORS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BIOREACTORS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BIOREACTORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BIOREACTORS MARKET SIZE, BY MECHANISM, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BIOREACTORS MARKET SIZE, BY MECHANISM, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BIOREACTORS MARKET SIZE, BY USAGE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BIOREACTORS MARKET SIZE, BY USAGE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL BIOREACTORS MARKET SIZE, BY MATERIAL, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL BIOREACTORS MARKET SIZE, BY MATERIAL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL BIOREACTORS MARKET SIZE, BY SCALE, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL BIOREACTORS MARKET SIZE, BY SCALE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. GLOBAL BIOREACTORS MARKET SIZE, BY USABILITY, 2023 VS 2030 (%)
• FIGURE 17. GLOBAL BIOREACTORS MARKET SIZE, BY USABILITY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. GLOBAL BIOREACTORS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 19. GLOBAL BIOREACTORS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. AMERICAS BIOREACTORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. AMERICAS BIOREACTORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. UNITED STATES BIOREACTORS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 23. UNITED STATES BIOREACTORS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. ASIA-PACIFIC BIOREACTORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 25. ASIA-PACIFIC BIOREACTORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 26. EUROPE, MIDDLE EAST & AFRICA BIOREACTORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 27. EUROPE, MIDDLE EAST & AFRICA BIOREACTORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 28. BIOREACTORS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 29. BIOREACTORS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BIOREACTORS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BIOREACTORS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BIOREACTORS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BIOREACTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BIOREACTORS MARKET DYNAMICS
• TABLE 7. GLOBAL BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BIOREACTORS MARKET SIZE, BY AIRLIFT BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BIOREACTORS MARKET SIZE, BY BENCHTOP BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BIOREACTORS MARKET SIZE, BY BUBBLE COLUMN BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BIOREACTORS MARKET SIZE, BY CONTINUOUS STIRRED TANK BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BIOREACTORS MARKET SIZE, BY FLUIDIZED BED BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BIOREACTORS MARKET SIZE, BY MICROBIAL BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BIOREACTORS MARKET SIZE, BY MULTI-PARALLEL BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BIOREACTORS MARKET SIZE, BY PACKED BED BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL BIOREACTORS MARKET SIZE, BY PHOTO-BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL BIOREACTORS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL BIOREACTORS MARKET SIZE, BY FULL-SCALE PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL BIOREACTORS MARKET SIZE, BY LAB-SCALE PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL BIOREACTORS MARKET SIZE, BY PILOT-SCALE PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL BIOREACTORS MARKET SIZE, BY AUTOMATED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL BIOREACTORS MARKET SIZE, BY MANUAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL BIOREACTORS MARKET SIZE, BY GLASS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL BIOREACTORS MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL BIOREACTORS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL BIOREACTORS MARKET SIZE, BY 1500L-4000L, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL BIOREACTORS MARKET SIZE, BY 200L-1500L, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL BIOREACTORS MARKET SIZE, BY 20L-200L, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL BIOREACTORS MARKET SIZE, BY 5L-20L, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL BIOREACTORS MARKET SIZE, BY ABOVE 4000L, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL BIOREACTORS MARKET SIZE, BY REUSABLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL BIOREACTORS MARKET SIZE, BY SINGLE-USE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL BIOREACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL BIOREACTORS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES & MANUFACTURERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL BIOREACTORS MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS & CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL BIOREACTORS MARKET SIZE, BY LANDFILLS & WASTE TREATMENT PLANTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 40. GLOBAL BIOREACTORS MARKET SIZE, BY R&D DEPARTMENTS & INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 42. AMERICAS BIOREACTORS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 43. AMERICAS BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2030 (USD MILLION)
• TABLE 44. AMERICAS BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 45. AMERICAS BIOREACTORS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
• TABLE 46. AMERICAS BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 47. AMERICAS BIOREACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 48. AMERICAS BIOREACTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 49. ARGENTINA BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 50. ARGENTINA BIOREACTORS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 51. ARGENTINA BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2030 (USD MILLION)
• TABLE 52. ARGENTINA BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 53. ARGENTINA BIOREACTORS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
• TABLE 54. ARGENTINA BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 55. ARGENTINA BIOREACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 56. BRAZIL BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 57. BRAZIL BIOREACTORS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 58. BRAZIL BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2030 (USD MILLION)
• TABLE 59. BRAZIL BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 60. BRAZIL BIOREACTORS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
• TABLE 61. BRAZIL BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 62. BRAZIL BIOREACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 63. CANADA BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 64. CANADA BIOREACTORS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 65. CANADA BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2030 (USD MILLION)
• TABLE 66. CANADA BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 67. CANADA BIOREACTORS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
• TABLE 68. CANADA BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 69. CANADA BIOREACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 70. MEXICO BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 71. MEXICO BIOREACTORS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 72. MEXICO BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2030 (USD MILLION)
• TABLE 73. MEXICO BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 74. MEXICO BIOREACTORS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
• TABLE 75. MEXICO BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 76. MEXICO BIOREACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 77. UNITED STATES BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 78. UNITED STATES BIOREACTORS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 79. UNITED STATES BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2030 (USD MILLION)
• TABLE 80. UNITED STATES BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 81. UNITED STATES BIOREACTORS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
• TABLE 82. UNITED STATES BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 83. UNITED STATES BIOREACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 84. UNITED STATES BIOREACTORS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 85. ASIA-PACIFIC BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 86. ASIA-PACIFIC BIOREACTORS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 87. ASIA-PACIFIC BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2030 (USD MILLION)
• TABLE 88. ASIA-PACIFIC BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 89. ASIA-PACIFIC BIOREACTORS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
• TABLE 90. ASIA-PACIFIC BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 91. ASIA-PACIFIC BIOREACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 92. ASIA-PACIFIC BIOREACTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 93. AUSTRALIA BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 94. AUSTRALIA BIOREACTORS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 95. AUSTRALIA BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2030 (USD MILLION)
• TABLE 96. AUSTRALIA BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 97. AUSTRALIA BIOREACTORS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
• TABLE 98. AUSTRALIA BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 99. AUSTRALIA BIOREACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 100. CHINA BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 101. CHINA BIOREACTORS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 102. CHINA BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2030 (USD MILLION)
• TABLE 103. CHINA BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 104. CHINA BIOREACTORS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
• TABLE 105. CHINA BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 106. CHINA BIOREACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 107. INDIA BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 108. INDIA BIOREACTORS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 109. INDIA BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2030 (USD MILLION)
• TABLE 110. INDIA BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 111. INDIA BIOREACTORS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
• TABLE 112. INDIA BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 113. INDIA BIOREACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 114. INDONESIA BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 115. INDONESIA BIOREACTORS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 116. INDONESIA BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2030 (USD MILLION)
• TABLE 117. INDONESIA BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 118. INDONESIA BIOREACTORS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
• TABLE 119. INDONESIA BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 120. INDONESIA BIOREACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 121. JAPAN BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 122. JAPAN BIOREACTORS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 123. JAPAN BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2030 (USD MILLION)
• TABLE 124. JAPAN BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 125. JAPAN BIOREACTORS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
• TABLE 126. JAPAN BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 127. JAPAN BIOREACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 128. MALAYSIA BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 129. MALAYSIA BIOREACTORS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 130. MALAYSIA BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2030 (USD MILLION)
• TABLE 131. MALAYSIA BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 132. MALAYSIA BIOREACTORS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
• TABLE 133. MALAYSIA BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 134. MALAYSIA BIOREACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 135. PHILIPPINES BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 136. PHILIPPINES BIOREACTORS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 137. PHILIPPINES BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2030 (USD MILLION)
• TABLE 138. PHILIPPINES BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 139. PHILIPPINES BIOREACTORS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
• TABLE 140. PHILIPPINES BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 141. PHILIPPINES BIOREACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 142. SINGAPORE BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 143. SINGAPORE BIOREACTORS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 144. SINGAPORE BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2030 (USD MILLION)
• TABLE 145. SINGAPORE BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 146. SINGAPORE BIOREACTORS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
• TABLE 147. SINGAPORE BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 148. SINGAPORE BIOREACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 149. SOUTH KOREA BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 150. SOUTH KOREA BIOREACTORS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 151. SOUTH KOREA BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2030 (USD MILLION)
• TABLE 152. SOUTH KOREA BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 153. SOUTH KOREA BIOREACTORS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
• TABLE 154. SOUTH KOREA BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 155. SOUTH KOREA BIOREACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 156. TAIWAN BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 157. TAIWAN BIOREACTORS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 158. TAIWAN BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2030 (USD MILLION)
• TABLE 159. TAIWAN BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 160. TAIWAN BIOREACTORS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
• TABLE 161. TAIWAN BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 162. TAIWAN BIOREACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 163. THAILAND BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 164. THAILAND BIOREACTORS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 165. THAILAND BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2030 (USD MILLION)
• TABLE 166. THAILAND BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 167. THAILAND BIOREACTORS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
• TABLE 168. THAILAND BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 169. THAILAND BIOREACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 170. VIETNAM BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 171. VIETNAM BIOREACTORS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 172. VIETNAM BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2030 (USD MILLION)
• TABLE 173. VIETNAM BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 174. VIETNAM BIOREACTORS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
• TABLE 175. VIETNAM BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 176. VIETNAM BIOREACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 177. EUROPE, MIDDLE EAST & AFRICA BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 178. EUROPE, MIDDLE EAST & AFRICA BIOREACTORS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 179. EUROPE, MIDDLE EAST & AFRICA BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2030 (USD MILLION)
• TABLE 180. EUROPE, MIDDLE EAST & AFRICA BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 181. EUROPE, MIDDLE EAST & AFRICA BIOREACTORS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
• TABLE 182. EUROPE, MIDDLE EAST & AFRICA BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 183. EUROPE, MIDDLE EAST & AFRICA BIOREACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 184. EUROPE, MIDDLE EAST & AFRICA BIOREACTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 185. DENMARK BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 186. DENMARK BIOREACTORS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 187. DENMARK BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2030 (USD MILLION)
• TABLE 188. DENMARK BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 189. DENMARK BIOREACTORS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
• TABLE 190. DENMARK BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 191. DENMARK BIOREACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 192. EGYPT BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 193. EGYPT BIOREACTORS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 194. EGYPT BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2030 (USD MILLION)
• TABLE 195. EGYPT BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 196. EGYPT BIOREACTORS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
• TABLE 197. EGYPT BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 198. EGYPT BIOREACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 199. FINLAND BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 200. FINLAND BIOREACTORS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 201. FINLAND BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2030 (USD MILLION)
• TABLE 202. FINLAND BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 203. FINLAND BIOREACTORS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
• TABLE 204. FINLAND BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 205. FINLAND BIOREACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 206. FRANCE BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 207. FRANCE BIOREACTORS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 208. FRANCE BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2030 (USD MILLION)
• TABLE 209. FRANCE BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 210. FRANCE BIOREACTORS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
• TABLE 211. FRANCE BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 212. FRANCE BIOREACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 213. GERMANY BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 214. GERMANY BIOREACTORS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 215. GERMANY BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2030 (USD MILLION)
• TABLE 216. GERMANY BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 217. GERMANY BIOREACTORS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
• TABLE 218. GERMANY BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 219. GERMANY BIOREACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 220. ISRAEL BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 221. ISRAEL BIOREACTORS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 222. ISRAEL BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2030 (USD MILLION)
• TABLE 223. ISRAEL BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 224. ISRAEL BIOREACTORS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
• TABLE 225. ISRAEL BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 226. ISRAEL BIOREACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 227. ITALY BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 228. ITALY BIOREACTORS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 229. ITALY BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2030 (USD MILLION)
• TABLE 230. ITALY BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 231. ITALY BIOREACTORS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
• TABLE 232. ITALY BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 233. ITALY BIOREACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 234. NETHERLANDS BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 235. NETHERLANDS BIOREACTORS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 236. NETHERLANDS BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2030 (USD MILLION)
• TABLE 237. NETHERLANDS BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 238. NETHERLANDS BIOREACTORS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
• TABLE 239. NETHERLANDS BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 240. NETHERLANDS BIOREACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 241. NIGERIA BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 242. NIGERIA BIOREACTORS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 243. NIGERIA BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2030 (USD MILLION)
• TABLE 244. NIGERIA BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 245. NIGERIA BIOREACTORS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
• TABLE 246. NIGERIA BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 247. NIGERIA BIOREACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 248. NORWAY BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 249. NORWAY BIOREACTORS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 250. NORWAY BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2030 (USD MILLION)
• TABLE 251. NORWAY BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 252. NORWAY BIOREACTORS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
• TABLE 253. NORWAY BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 254. NORWAY BIOREACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 255. POLAND BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 256. POLAND BIOREACTORS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 257. POLAND BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2030 (USD MILLION)
• TABLE 258. POLAND BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 259. POLAND BIOREACTORS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
• TABLE 260. POLAND BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 261. POLAND BIOREACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 262. QATAR BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 263. QATAR BIOREACTORS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 264. QATAR BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2030 (USD MILLION)
• TABLE 265. QATAR BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 266. QATAR BIOREACTORS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
• TABLE 267. QATAR BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 268. QATAR BIOREACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 269. RUSSIA BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 270. RUSSIA BIOREACTORS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 271. RUSSIA BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2030 (USD MILLION)
• TABLE 272. RUSSIA BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 273. RUSSIA BIOREACTORS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
• TABLE 274. RUSSIA BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 275. RUSSIA BIOREACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 276. SAUDI ARABIA BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 277. SAUDI ARABIA BIOREACTORS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 278. SAUDI ARABIA BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2030 (USD MILLION)
• TABLE 279. SAUDI ARABIA BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 280. SAUDI ARABIA BIOREACTORS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
• TABLE 281. SAUDI ARABIA BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 282. SAUDI ARABIA BIOREACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 283. SOUTH AFRICA BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 284. SOUTH AFRICA BIOREACTORS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 285. SOUTH AFRICA BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2030 (USD MILLION)
• TABLE 286. SOUTH AFRICA BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 287. SOUTH AFRICA BIOREACTORS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
• TABLE 288. SOUTH AFRICA BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 289. SOUTH AFRICA BIOREACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 290. SPAIN BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 291. SPAIN BIOREACTORS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 292. SPAIN BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2030 (USD MILLION)
• TABLE 293. SPAIN BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 294. SPAIN BIOREACTORS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
• TABLE 295. SPAIN BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 296. SPAIN BIOREACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 297. SWEDEN BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 298. SWEDEN BIOREACTORS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 299. SWEDEN BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2030 (USD MILLION)
• TABLE 300. SWEDEN BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 301. SWEDEN BIOREACTORS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
• TABLE 302. SWEDEN BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 303. SWEDEN BIOREACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 304. SWITZERLAND BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 305. SWITZERLAND BIOREACTORS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 306. SWITZERLAND BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2030 (USD MILLION)
• TABLE 307. SWITZERLAND BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 308. SWITZERLAND BIOREACTORS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
• TABLE 309. SWITZERLAND BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 310. SWITZERLAND BIOREACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 311. TURKEY BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 312. TURKEY BIOREACTORS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 313. TURKEY BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2030 (USD MILLION)
• TABLE 314. TURKEY BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 315. TURKEY BIOREACTORS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
• TABLE 316. TURKEY BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 317. TURKEY BIOREACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 318. UNITED ARAB EMIRATES BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 319. UNITED ARAB EMIRATES BIOREACTORS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 320. UNITED ARAB EMIRATES BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2030 (USD MILLION)
• TABLE 321. UNITED ARAB EMIRATES BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 322. UNITED ARAB EMIRATES BIOREACTORS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
• TABLE 323. UNITED ARAB EMIRATES BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 324. UNITED ARAB EMIRATES BIOREACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 325. UNITED KINGDOM BIOREACTORS MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 326. UNITED KINGDOM BIOREACTORS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 327. UNITED KINGDOM BIOREACTORS MARKET SIZE, BY CONTROL TYPE, 2018-2030 (USD MILLION)
• TABLE 328. UNITED KINGDOM BIOREACTORS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 329. UNITED KINGDOM BIOREACTORS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
• TABLE 330. UNITED KINGDOM BIOREACTORS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 331. UNITED KINGDOM BIOREACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 332. BIOREACTORS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 333. BIOREACTORS MARKET, FPNV POSITIONING MATRIX, 2023

The Bioreactors Market was valued at USD 3.26 billion in 2023, expected to reach USD 3.57 billion in 2024, and is projected to grow at a CAGR of 9.46%, to USD 6.15 billion by 2030.

Bioreactors are essential components in the biomanufacturing industry, playing a critical role in the cultivation of microorganisms, cells, and tissues for the production of pharmaceuticals, biofuels, and other products. The necessity for bioreactors arises from the growing demand for biologics and sustainable energy solutions, which drive advancements in biotechnology and industrial processes. Their applications span pharmaceutical manufacturing, wastewater treatment, food and beverage industry, and agriculture, with end-users primarily being pharmaceutical companies, research labs, and environmental agencies. The market for bioreactors is significantly influenced by technological advancements such as automated controls and improved monitoring systems, which enhance efficiency and yield. Opportunities in the market are abundant, with personalized medicine and regenerative therapies offering new avenues for growth. To capitalize on these opportunities, companies should invest in collaborative research efforts that focus on improving scalability and production yields. However, the market faces challenges such as high initial investment costs, complex regulatory frameworks, and technical issues related to contamination and scalability. Addressing these limitations requires innovation in design and process optimization. Moreover, the emphasis on single-use bioreactors in response to their cost-effective and lower contamination risks presents a promising area for innovation. Research in bioreactor design focusing on modularity and adaptability could further support business growth. The nature of the bioreactor market is highly dynamic, driven by rapid technological advancements and evolving consumer demands for biopharmaceuticals and sustainable products. Strategic partnerships and mergers could provide a competitive edge, ensuring access to critical resources and technological expertise. In summary, the future of the bioreactor market lies in continuous innovation, precise regulatory navigation, and strategic positioning to effectively respond to emerging trends and consumer needs.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bioreactors Market

The Bioreactors Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rapid growth of biopharmaceuticals and biologics industries
  • Adoption of single-use bioreactors (subs) and hybrid bioreactors
• Market Restraints
  • Maintenance issues and high power consumption issues with bioreactors
• Market Opportunities
  • Continuous technological advancements in the development of novel bioreactors
  • High potential of bioreactors in the wastewater treatment process
• Market Challenges
  • Safety and environmental concerns associated with the use of bioreactors

Porter's Five Forces: A Strategic Tool for Navigating the Bioreactors Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bioreactors Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bioreactors Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bioreactors Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bioreactors Market

A detailed market share analysis in the Bioreactors Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bioreactors Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bioreactors Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Bioreactors Market, highlighting leading vendors and their innovative profiles. These include 3D Biotek LLC, ABEC, Inc., Adolf Kuhner AG, BBI-biotech GmbH, Belach Bioteknik AB legal, Bioengineering AG, Bionet Servicios Tecnicos, SL, Broadley-James Corporation, Cell Culture Company, LLC, Cellexus Limited, CerCell A/S, Cesco Bioengineering Co., Ltd. acquired by Esco Lifescience Group, Danaher Corporation, Distek, Inc., Electrolab Biotech Limited, Eppendorf SE, FiberCell Systems Inc., G&G Technologies, Inc., GEA Group AG, Getinge AB, IKA-Werke GmbH & CO. KG, Infors AG, Lonza Group AG, Merck KGaA, PBS Biotech, Inc., Pierre Guerin SAS, Praj Industries Limited, Sartorius AG, Shanghai LePure Biotech Co., Ltd., Solaris Biotechnolgy Srl by Donaldson Company, Inc., Solida Biotech GmBH, Terumo Corporation, Thermo Fisher Scientific Inc., WuXi Biologics (Cayman) Inc., and ZETA GmbH.

Market Segmentation & Coverage

This research report categorizes the Bioreactors Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Mechanism, market is studied across Airlift Bioreactors, Benchtop Bioreactors, Bubble Column Bioreactors, Continuous Stirred Tank Bioreactors, Fluidized Bed Bioreactors, Microbial Bioreactors, Multi-Parallel Bioreactors, Packed Bed Bioreactors, and Photo-Bioreactors.
• Based on Usage, market is studied across Full-scale Production, Lab-Scale Production, and Pilot-scale Production.
• Based on Control Type, market is studied across Automated and Manual.
• Based on Material, market is studied across Glass and Stainless Steel.
• Based on Scale, market is studied across 1500L-4000L, 200L-1500L, 20L-200L, 5L-20L, and Above 4000L.
• Based on Usability, market is studied across Reusable and Single-use.
• Based on End User, market is studied across Biopharmaceutical Companies & Manufacturers, Contract Manufacturing Organizations & Contract Research Organizations, Landfills & Waste Treatment Plants, and R&D Departments & Institutes.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rapid growth of biopharmaceuticals and biologics industries
    • 5.1.1.2. Adoption of single-use bioreactors (subs) and hybrid bioreactors
  • 5.1.2. Restraints
    • 5.1.2.1. Maintenance issues and high power consumption issues with bioreactors
  • 5.1.3. Opportunities
    • 5.1.3.1. Continuous technological advancements in the development of novel bioreactors
    • 5.1.3.2. High potential of bioreactors in the wastewater treatment process
  • 5.1.4. Challenges
    • 5.1.4.1. Safety and environmental concerns associated with the use of bioreactors
• 5.2. Market Segmentation Analysis
  • 5.2.1. Mechanism: Adoption of photo-bioreactors for the growth of photosynthetic microorganisms
  • 5.2.2. Usage: Preferences for full-scale production from various industries due to large volume processing capacity
  • 5.2.3. Control Type: Adoption of automated bioreactors due to high level of precision and consistency in process control
  • 5.2.4. Material : Increasing usage of stainless steel bioreactors in the pharmaceutical and biotech industries owing to their durability and scalability
  • 5.2.5. Scale: Suitability of 200L-1500L bioreactors for pilot-scale and small-scale commercial manufacturing processes
  • 5.2.6. Usability: Preferences for single-use bioreactors due to their flexibility, & reduced risk of cross-contamination
  • 5.2.7. End User: Increasing applicability in biopharmaceutical industry, for producing biotherapeutics including monoclonal antibodies & vaccines
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Bioreactors Market, by Mechanism

• 6.1. Introduction
• 6.2. Airlift Bioreactors
• 6.3. Benchtop Bioreactors
• 6.4. Bubble Column Bioreactors
• 6.5. Continuous Stirred Tank Bioreactors
• 6.6. Fluidized Bed Bioreactors
• 6.7. Microbial Bioreactors
• 6.8. Multi-Parallel Bioreactors
• 6.9. Packed Bed Bioreactors
• 6.10. Photo-Bioreactors

7. Bioreactors Market, by Usage

• 7.1. Introduction
• 7.2. Full-scale Production
• 7.3. Lab-Scale Production
• 7.4. Pilot-scale Production

8. Bioreactors Market, by Control Type

• 8.1. Introduction
• 8.2. Automated
• 8.3. Manual

9. Bioreactors Market, by Material

• 9.1. Introduction
• 9.2. Glass
• 9.3. Stainless Steel

10. Bioreactors Market, by Scale

• 10.1. Introduction
• 10.2. 1500L-4000L
• 10.3. 200L-1500L
• 10.4. 20L-200L
• 10.5. 5L-20L
• 10.6. Above 4000L

11. Bioreactors Market, by Usability

• 11.1. Introduction
• 11.2. Reusable
• 11.3. Single-use

12. Bioreactors Market, by End User

• 12.1. Introduction
• 12.2. Biopharmaceutical Companies & Manufacturers
• 12.3. Contract Manufacturing Organizations & Contract Research Organizations
• 12.4. Landfills & Waste Treatment Plants
• 12.5. R&D Departments & Institutes

13. Americas Bioreactors Market

• 13.1. Introduction
• 13.2. Argentina
• 13.3. Brazil
• 13.4. Canada
• 13.5. Mexico
• 13.6. United States

14. Asia-Pacific Bioreactors Market

• 14.1. Introduction
• 14.2. Australia
• 14.3. China
• 14.4. India
• 14.5. Indonesia
• 14.6. Japan
• 14.7. Malaysia
• 14.8. Philippines
• 14.9. Singapore
• 14.10. South Korea
• 14.11. Taiwan
• 14.12. Thailand
• 14.13. Vietnam

15. Europe, Middle East & Africa Bioreactors Market

• 15.1. Introduction
• 15.2. Denmark
• 15.3. Egypt
• 15.4. Finland
• 15.5. France
• 15.6. Germany
• 15.7. Israel
• 15.8. Italy
• 15.9. Netherlands
• 15.10. Nigeria
• 15.11. Norway
• 15.12. Poland
• 15.13. Qatar
• 15.14. Russia
• 15.15. Saudi Arabia
• 15.16. South Africa
• 15.17. Spain
• 15.18. Sweden
• 15.19. Switzerland
• 15.20. Turkey
• 15.21. United Arab Emirates
• 15.22. United Kingdom

16. Competitive Landscape

• 16.1. Market Share Analysis, 2023
• 16.2. FPNV Positioning Matrix, 2023
• 16.3. Competitive Scenario Analysis
  • 16.3.1. Expansion in Denmark doubles AGC Biologics' bioreactor capacity to meet growing biopharma demand
  • 16.3.2. WuXi exemplifies strategic bioprocessing expansion with bioreactor integration to meet growing biologics demand
  • 16.3.3. Caladan Bio revolutionizes biotechnology with USD 5 million seed round for innovative benchtop bioreactors
  • 16.3.4. Sartorius Bioreactors Integrate Emerson Technology to Speed New Therapies to Market
  • 16.3.5. Merger of Cytiva and Pall's Life Sciences Business Now Complete
  • 16.3.6. PBS Biotech and denovoMATRIX Join Forces to Boost Manufacturing Processes for Cell & Gene Therapies
  • 16.3.7. Lonza and Adva Biotechnology Ltd. Agree to Expand Availability and Use of Automated Bioreactors with License to Lonza's Patents
  • 16.3.8. Novo Holdings co-leads Series C financing in LePure Biotech
  • 16.3.9. PBS Biotech Raises USD 22 million to Expand Single-Use Manufacturing Products and Services for Cell Therapy Clients
  • 16.3.10. Merck Gains Leading Perfusion Micro-Bioreactor with Erbi Biosystems Acquisition
  • 16.3.11. Solaris Biotech and Wildtype Announce Agreement for Large-scale Bioreactors for Cultivated Seafood Production
  • 16.3.12. STEMCELL Technologies and PBS Biotech Partner to Enable Robust Scale Up of Human Pluripotent Stem Cell 3D Cultures
  • 16.3.13. Stamm Biotech Raises USD 17 Million To Develop Desktop 3D Printed Bioreactor

Companies Mentioned

• 1. 3D Biotek LLC
• 2. ABEC, Inc.
• 3. Adolf Kuhner AG
• 4. BBI-biotech GmbH
• 5. Belach Bioteknik AB legal
• 6. Bioengineering AG
• 7. Bionet Servicios Tecnicos, SL
• 8. Broadley-James Corporation
• 9. Cell Culture Company, LLC
• 10. Cellexus Limited
• 11. CerCell A/S
• 12. Cesco Bioengineering Co., Ltd. acquired by Esco Lifescience Group
• 13. Danaher Corporation
• 14. Distek, Inc.
• 15. Electrolab Biotech Limited
• 16. Eppendorf SE
• 17. FiberCell Systems Inc.
• 18. G&G Technologies, Inc.
• 19. GEA Group AG
• 20. Getinge AB
• 21. IKA-Werke GmbH & CO. KG
• 22. Infors AG
• 23. Lonza Group AG
• 24. Merck KGaA
• 25. PBS Biotech, Inc.
• 26. Pierre Guerin SAS
• 27. Praj Industries Limited
• 28. Sartorius AG
• 29. Shanghai LePure Biotech Co., Ltd.
• 30. Solaris Biotechnolgy Srl by Donaldson Company, Inc.
• 31. Solida Biotech GmBH
• 32. Terumo Corporation
• 33. Thermo Fisher Scientific Inc.
• 34. WuXi Biologics (Cayman) Inc.
• 35. ZETA GmbH